As of Aug 16
| +0.12 / +2.06%|
The 8 analysts offering 12-month price forecasts for TherapeuticsMD Inc have a median target of 11.50, with a high estimate of 33.00 and a low estimate of 8.00. The median estimate represents a +93.60% increase from the last price of 5.94.
The current consensus among 8 polled investment analysts is to Buy stock in TherapeuticsMD Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.